Charles Joyner, MD
Clinical Cardiac Electrophysiology · Richmond, VANPI 1609897206
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Johnson & Johnson at 47.8% of the total. Reporting peaked in 2019 at $41,252 and has fallen 87.8% since, to $5,022 in 2025.
Across 259 payments — averaging $326.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$40K
- Boston Scientific$32K
- Medtronic$8K
- Abbott$1K
- Cardiva Medical, Inc.$547
- Biosense Webster, Inc.$417
- plus $2K from 27 others
Across 80 payments — averaging $1740.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$102K
- Cardiva Medical, Inc.$37K
What the payments were for
- Consulting fees$25,87531%
- Speaking & faculty fees$38,84546%
- Travel & lodging$8,48510%
- Food & beverage$11,29713%
- Entertainment$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 37 | $40,391 |
| Boston Scientific | 97 | $31,654 |
| Medtronic(2 entities) | 15 | $7,928 |
| Abbott | 22 | $1,364 |
| Cardiva Medical, Inc. | 15 | $547 |
| Biosense Webster, Inc. | 5 | $417 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $344 |
| Impulse Dynamics (USA) Inc. | 3 | $260 |
| Merit Medical Systems Inc | 1 | $250 |
| Abiomed | 2 | $161 |
| Philips North America LLC | 2 | $153 |
| Pfizer | 6 | $150 |
| AstraZeneca | 2 | $123 |
| Novartis | 7 | $113 |
| Boehringer Ingelheim | 6 | $105 |
| Atricure, Inc. | 3 | $78 |
| Bardy Diagnostics, Inc. | 3 | $64 |
| Alnylam Pharmaceuticals Inc. | 4 | $62 |
| Kestra Medical Technology Services, Inc. | 3 | $57 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| Novo Nordisk | 1 | $35 |
| Scpharmaceuticals Inc. | 1 | $29 |
| Vital Connect, Inc | 1 | $27 |
| Angiodynamics, Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| Amgen | 1 | $16 |
| Cordis US CORP. | 1 | $16 |
| Bard Access Systems, Inc. | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Elutia, Inc. | 1 | $14 |
| Itamar Medical Inc | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$39,790
- GENERAL - THERAPIES$21,943
- PlasmaBlade$3,876
- Watchman$822
- OPTIMIZER$352
- Farapulse$340
- WATCHMAN Access System$278
- Perclose ProStyle$256
- Carto 3$249
- AVEIR$227
- ACCOLADE SR$206
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$150
- LUX-Dx Insertable Cardiac Monitor$144
- COBALT DR MRI SURESCAN$137
- NUVISION ICE CATHETER$133
- (9520) IGT Devices Undivided$125
- Mitra Clip system$124
- PERCLOSE PROGLIDE$123
- AFFERA MAPPING SYSTEM$107
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$105
How this compares
$84,515 in reported general payments places this provider in the 85th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 436 | $441,313 |
| XareltoRivaroxaban | 250 | $230,915 |
| EntrestoSacubitril/Valsartan | 19 | $23,068 |
| Flecainide Acetate | 237 | $9,102 |
| Amiodarone Hcl | 226 | $7,716 |
| Dofetilide | 26 | $5,743 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 19 | $5,122 |
| Metoprolol Succinate | 413 | $4,581 |
| Mexiletine Hcl | 29 | $1,837 |
| SotalolSotalol Hcl | 103 | $1,715 |
| Carvedilol | 107 | $1,071 |
| Propafenone Hcl | 11 | $842 |
| Losartan Potassium | 91 | $667 |
| Nebivolol Hcl | 19 | $661 |
| Metoprolol Tartrate | 105 | $585 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $150 | $441,313436 claims |
| Johnson & JohnsonXarelto | $40,391 | $230,915250 claims |
| NovartisEntresto | $113 | $23,06819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Richmond
- Kenneth EllenbogenRichmond$360K
- Ajay PillaiRichmond$129K
- Binaya BasyalRichmond$79K
- Jayanthi KoneruRichmond$62K
- Kyaw Min KhantRichmond$51K
- Jacob BlackwellRichmond$49K
- Pranav MankadRichmond$30K
- Vybhav JettyRichmond$20K
- Harsimran SainiRichmond$17K
- David GilliganRichmond$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.